Adicet Bio Inc (ACET)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | KLICKSTEIN, LLOYD | Director, Chief Medical Officer | Stock Option (Right to Buy) | Acquisition | 18,300 | 0 |
| Jun 21, 2026 | CHODAKEWITZ, JEFFREY | Director | Stock Option (Right to Buy) | Acquisition | 4,200 | 0 |
| Jun 21, 2026 | GRISSINGER, MICHAEL | Director | Stock Option (Right to Buy) | Acquisition | 4,200 | 0 |
| Jun 21, 2026 | KLICKSTEIN, LLOYD | Director | Stock Option (Right to Buy) | Acquisition | 4,200 | 0 |
| Jun 21, 2026 | SINCLAIR, ANDREW | Director | Stock Option (Right to Buy) | Acquisition | 4,200 | 0 |
| Jun 21, 2026 | PENG, KATIE | Director | Stock Option (Right to Buy) | Acquisition | 4,200 | 0 |
| Jun 21, 2026 | DUBIN, STEVE | Director | Stock Option (Right to Buy) | Acquisition | 4,200 | 0 |
| Jun 19, 2026 | SCHOR, CHEN | Director, President & CEO | Stock Option (Right to Buy) | Acquisition | 55,000 | 0 |
| Jun 19, 2026 | AFTAB, BLAKE | Chief Scientific Officer | Stock Option (Right to Buy) | Acquisition | 55,000 | 0 |
| Apr 27, 2026 | RA, CAPITAL MANAGEMENT, L.P. | 10% Owner | Common Stock | Disposal | 250,000 | |
| Apr 27, 2026 | RA, CAPITAL MANAGEMENT, L.P. | 10% Owner | Pre-Funded Warrant (Right to Buy) | Acquisition | 250,000 | |
| Apr 8, 2026 | ORBIMED, ADVISORS LLC | 10% Owner | Common Stock | Disposal | 32,523 | 6.29 |
| Apr 8, 2026 | ORBIMED, ADVISORS LLC | 10% Owner | Common Stock | Disposal | 40,416 | 6.52 |
| Apr 7, 2026 | ORBIMED, ADVISORS LLC | 10% Owner | Common Stock | Disposal | 29,319 | 6.53 |
| Apr 7, 2026 | ORBIMED, ADVISORS LLC | 10% Owner | Common Stock | Disposal | 2,400 | 6.38 |
| Mar 25, 2026 | SCHOR, CHEN | Director, President & CEO | Stock Option (Right to Buy) | Acquisition | 468,555 | 0 |
| Mar 25, 2026 | MALTZMAN, JULIA D. | Chief Medical Officer | Stock Option (Right to Buy) | Acquisition | 72,555 | 0 |
| Mar 25, 2026 | HEALEY, DON | Chief Technology Officer | Stock Option (Right to Buy) | Acquisition | 43,361 | 0 |
| Mar 25, 2026 | HARVEY, BRIAN NICHOLAS | Chief Financial Officer | Stock Option (Right to Buy) | Acquisition | 43,361 | 0 |
| Mar 25, 2026 | AFTAB, BLAKE | Chief Scientific Officer | Stock Option (Right to Buy) | Acquisition | 72,555 | 0 |
| Feb 20, 2026 | RA, CAPITAL MANAGEMENT, L.P. | 10% Owner | Common Stock | Acquisition | 74,751 | 7.27 |
| Feb 19, 2026 | RA, CAPITAL MANAGEMENT, L.P. | 10% Owner | Common Stock | Acquisition | 74,268 | 7.21 |
| Feb 18, 2026 | RA, CAPITAL MANAGEMENT, L.P. | 10% Owner | Common Stock | Acquisition | 74,577 | 7.04 |
| Jan 24, 2026 | HEALEY, DON | Chief Technology Officer | Common Stock | Disposal | 535 | 8.44 |
| Jan 24, 2026 | AFTAB, BLAKE | Chief Scientific Officer | Common Stock | Disposal | 535 | 8.44 |
| Jan 24, 2026 | HARVEY, BRIAN NICHOLAS | Chief Financial Officer | Common Stock | Disposal | 546 | 8.44 |
| Jan 24, 2026 | SCHOR, CHEN | Director, President & CEO | Common Stock | Disposal | 1,755 | 8.44 |
| Oct 8, 2025 | ORBIMED, ADVISORS LLC | 10% Owner | Common Stock | Acquisition | 3,500,000 | 1 |
| Oct 8, 2025 | ORBIMED, ADVISORS LLC | 10% Owner | Common Stock | Acquisition | 1,500,000 | 1 |